Gene · 51185
Papers2,935
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,221 to 1,240 of 2,935
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Targeted Degradation of 53BP1 Using Ubiquitin Variant Induced Proximity. | Biomolecules | 2022 | 35454069 | PubTator, text mining | PubMed |
| Integrative diagnosis of primary cutaneous large B-cell lymphomas supports the relevance of cell of origin profiling. | PLoS One | 2022 | 35452489 | PubTator, text mining | PubMed |
| Lysine methyltransferase inhibitors: where we are now. | RSC Chem Biol | 2022 | 35441141 | PubTator, text mining | PubMed |
| Environmental induced transgenerational inheritance impacts systems epigenetics in disease etiology. | Sci Rep | 2022 | 35440735 | PubTator, text mining | PubMed |
| Development of NanoLuc-targeting protein degraders and a universal reporter system to benchmark tag-targeted degradation platforms. | Nat Commun | 2022 | 35440107 | PubTator, text mining | PubMed |
| Case Report: Personalized Therapeutical Approaches with Lenalidomide in Del(5q): A Case Series. | Front Oncol | 2022 | 35433412 | PubTator, text mining | PubMed |
| IKZF1 selectively enhances homologous recombination repair by interacting with CtIP and USP7 in multiple myeloma. | Int J Biol Sci | 2022 | 35414773 | PubTator, text mining | PubMed |
| Discovery of potential novel CRBN modulators by virtual screening and bioassay. | Eur J Med Chem | 2022 | 35413617 | PubTator, text mining | PubMed |
| Proteolysis-targeting chimeras (PROTACs) in cancer therapy. | Mol Cancer | 2022 | 35410300 | PubTator, text mining | PubMed |
| Unleashing Cell-Intrinsic Inflammation as a Strategy to Kill AML Blasts. | Cancer Discov | 2022 | 35405016 | PubTator, text mining | PubMed |
| A platform for the rapid synthesis of proteolysis targeting chimeras (Rapid-TAC) under miniaturized conditions. | Eur J Med Chem | 2022 | 35397401 | PubTator, text mining | PubMed |
| A proteolysis-targeting chimera molecule selectively degrades ENL and inhibits malignant gene expression and tumor growth. | J Hematol Oncol | 2022 | 35395864 | PubTator, text mining | PubMed |
| Adjusted degradation of BRD4 S and BRD4 L based on fine structural modifications of the pyrrolopyridone scaffold. | Eur J Med Chem | 2022 | 35395439 | PubTator, text mining | PubMed |
| E3 ligase ligand chemistries: from building blocks to protein degraders. | Chem Soc Rev | 2022 | 35393989 | PubTator, text mining | PubMed |
| Redefining CD56 as a Biomarker and Therapeutic Target in Multiple Myeloma. | Mol Cancer Res | 2022 | 35380709 | PubTator, text mining | PubMed |
| Targeted protein degradation: mechanisms, strategies and application. | Signal Transduct Target Ther | 2022 | 35379777 | PubTator, text mining | PubMed |
| Allostery: Allosteric Cancer Drivers and Innovative Allosteric Drugs. | J Mol Biol | 2022 | 35378118 | PubTator, text mining | PubMed |
| Targeting Oncoproteins for Degradation by Small Molecule-Based Proteolysis-Targeting Chimeras (PROTACs) in Sex Hormone-Dependent Cancers. | Front Endocrinol (Lausanne) | 2022 | 35370971 | PubTator, text mining | PubMed |
| Exploring Methods of Targeting Histone Methyltransferases and Their Applications in Cancer Therapeutics. | ACS Chem Biol | 2022 | 35363464 | PubTator, text mining | PubMed |
| SIRPα+ macrophages are increased in patients with FL who progress or relapse after frontline lenalidomide and rituximab. | Blood Adv | 2022 | 35359004 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51185/papers?page=62